Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Holst

Showing results (241-250 of 1,570) with videos related to

Pageof 157
Sort By:
Digestive Diseases and Sciences|July 1, 1992
Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in manO Olsen, J J Holst, O B Schaffalitzky De Muckadell
Diabetologia|December 31, 2005
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetesM Zander, S Madsbad, C F Deacon, et al.
Scandinavian Journal of Gastroenterology|January 1, 1977
Plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HC1 in anaesthetized pigsO B Schaffalitzky de Muckadell, J Fahrenkrug, J J Holst
Diabetologia|June 1, 1995
Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationshipsR Ritzel, C Orskov, J J Holst, et al.
Clinical Science and Molecular Medicine|January 1, 1978
Elimination of porcine secretin in pigsJ Fahrenkrug, O B Schaffalitzky de Muckadell, J J Holst
Idrugs : the Investigational Drugs Journal|July 25, 2009
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Jens J Holst, et al.
Diabetes|January 1, 1992
Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wastingT P Almdal, J J Holst, H Heindorff, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|October 1, 1991
Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are autonomic cotransmitters in the porcine pancreasT Messell, B E Dunning, S Sheikh, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1979
[Glucagon-producing endocrine pancreas tumors. Symptoms, diagnosis, localization, therapy and follow-up]W Reichardt, M Ericsson, J Holst, et al.
The American Journal of Physiology|October 1, 1995
Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOSG E Holle, E Steinbach, E Wünsch, et al.
Pageof 157

Showing results (241-250 of 1,570) with videos related to

Sort By:
Pageof 157
Digestive Diseases and Sciences|July 1, 1992
Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in manO Olsen, J J Holst, O B Schaffalitzky De Muckadell
Diabetologia|December 31, 2005
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetesM Zander, S Madsbad, C F Deacon, et al.
Scandinavian Journal of Gastroenterology|January 1, 1977
Plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HC1 in anaesthetized pigsO B Schaffalitzky de Muckadell, J Fahrenkrug, J J Holst
Diabetologia|June 1, 1995
Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationshipsR Ritzel, C Orskov, J J Holst, et al.
Clinical Science and Molecular Medicine|January 1, 1978
Elimination of porcine secretin in pigsJ Fahrenkrug, O B Schaffalitzky de Muckadell, J J Holst
Idrugs : the Investigational Drugs Journal|July 25, 2009
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Jens J Holst, et al.
Diabetes|January 1, 1992
Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wastingT P Almdal, J J Holst, H Heindorff, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|October 1, 1991
Neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), but not galanin, are autonomic cotransmitters in the porcine pancreasT Messell, B E Dunning, S Sheikh, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1979
[Glucagon-producing endocrine pancreas tumors. Symptoms, diagnosis, localization, therapy and follow-up]W Reichardt, M Ericsson, J Holst, et al.
The American Journal of Physiology|October 1, 1995
Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOSG E Holle, E Steinbach, E Wünsch, et al.
Pageof 157